Workflow
骨导助听器
icon
Search documents
谭治平:打破西方垄断,“中国耳蜗”杭州造
Hang Zhou Ri Bao· 2025-06-20 02:44
Core Viewpoint - The article highlights the significant advancements and achievements of Zhejiang Norkang Neuroelectronic Technology Co., Ltd. in the field of neuroelectronic medical devices, particularly in the development of China's first self-researched cochlear implant, showcasing the company's commitment to innovation and domestic production [2][7][10]. Company Overview - Zhejiang Norkang is recognized as a national-level specialized and innovative "little giant" enterprise, focusing on the research and development of neuroelectronic medical devices [2]. - The company has successfully developed a world-first saddle-shaped electrode, breaking the technological monopoly held by Western countries [2][7]. Key Achievements - Norkang's cochlear implant has achieved a market share of 30% globally, ranking third overall and first among domestic brands, helping over 20,000 hearing-impaired patients [10]. - The company received the medical device certificate from the National Medical Products Administration in August 2011, marking it as the only Chinese company with independent intellectual property rights in this field [7]. Technological Innovations - The company has developed a 24-channel cochlear electrode, which is the most advanced in terms of the number of channels and the smallest diameter, achieving a significant technological breakthrough [7][8]. - Norkang's electrode technology has evolved from a cap shape to a more precise saddle shape, with the diameter reduced from 0.72 mm to 0.35 mm [7]. Market Impact - The initial pricing of Norkang's cochlear implant was set at 78,000 yuan, which is one-third of the price of imported devices, significantly reducing the financial burden on patients [10]. - The company has been included in centralized procurement programs in several provinces, allowing patients to access the implant for as low as 18,500 yuan [11]. Future Prospects - Norkang aims to achieve nearly 90% localization of raw materials for its cochlear implants and is actively working on overcoming challenges related to liquid silicone, a critical component [11]. - The company is committed to maintaining control over innovation and development, which will enhance its resilience against external shocks [11].